The Interagency Coalition on AIDS and Development (ICAD), the Canadian AIDS Society (CAS), CATIE and the Canadian Public Health Association (CPHA) were pleased to offer a webinar series on “New HIV prevention technologies and their implications for HIV prevention in Canada.” Please see below for further information on these webinars:
Webinar 1: New HIV Prevention Technologies (NPTs) – The basics and the state of research
12 July 2011
If you’re wondering what all the buzz is around new HIV prevention technologies, you’re not alone. Recent research advances have reinvigorated the field, with new findings around medical male circumcision, vaccines, microbicides and ARV-based prevention strategies.
View this webinar to learn about the basics of new HIV prevention technologies – what they are, what the research tells us and what it means in the Canadian context.
View a recording of the webinar (below) or the PowerPoint presentation.
Please note that the PowerPoint slides have been slightly altered to reflect important new information on pre-exposure prophylaxis (PrEP) trial results that were released the day after the call; the recording therefore does not reflect the changes made in the PowerPoint.
Webinar 2: Preparing for NPTs – Learning from the past and preparing for the future
27 July 2011
New prevention technologies like PrEP, microbicides and vaccines are starting to show promise in research studies. Advances in research raise questions about the challenges that exist for roll out in communities, how to ensure equitable access and how to successfully incorporate NPTs into the wider HIV prevention landscape.
View this webinar to learn about what’s already known about the potential challenges to NPT roll out and how to prepare for an HIV prevention landscape that includes NPTs.
View a recording of the webinar and the PowerPoint presentation on CAS’ website.
Webinar 3: Can we prevent infection with HIV after an exposure? The world of post-exposure prophylaxis (PEP)
3 August 2011
Much of the work we do in HIV prevention is aimed at trying to stop people from engaging in behaviours that could expose them to HIV and potentially lead to infection. But what happens if someone thinks they may have recently been exposed to HIV? Is there a way we can stop them from getting infected? Post-exposure prophylaxis, or PEP, could be an option.
View this webinar to learn about how PEP works, when it can be used, and why it isn’t more available for certain types of exposures.
Webinar 4: Preparing for pre-exposure prophylaxis (PrEP) to prevent HIV infection
10 August 2011
What if a person at risk of HIV infection could start taking preventative medications on a regular basis before being exposed to HIV in order to reduce their risk of infection? This strategy, known as pre-exposure prophylaxis (or PrEP), is beginning to show promise in research studies and could potentially provide another much needed prevention option for those at risk of infection. Despite its promise, this strategy raises a number of concerns and – if we aren’t prepared – its introduction could end up doing more harm than good.
View this webinar to learn about the PrEP research, the concerns that PrEP raises, and how we can make sure these concerns are avoided.
Webinar 5: Are people living with HIV less likely to pass HIV to others if they are on treatment? Exploring the use of treatment as prevention
24 August 2011
You may have heard that people living with HIV are less likely to pass HIV to others if they are on treatment – a strategy often referred to as “treatment as prevention”- but many misconceptions and unanswered questions still remain. How effective is treatment at reducing the risk of transmission? Does an undetectable blood viral load mean that someone can’t transmit HIV through unprotected sex? What exactly is a “test and treat” strategy?
View this webinar to learn the answers to these questions and get updated on the latest research.